Beung‐Chul Ahn - Concepedia

Author

Beung‐Chul Ahn

Also Known As

Ahn, Beung-Chul, B. Ahn, B.-C. Ahn, B.C. Ahn, Beomhee Ahn Ahn, Beung -Chul Ahn, Beung Chul AHN, Beung Chul Ahn, Beung-Chul AHN, Beung-Chul Ahn

Publications

940

Citations

H-Index

Concepts

All Affiliations

Yonsei University Severance Hospital Jeuk (South Korea)National Cancer Center Seoul National University

About

Beung‐Chul Ahn is an author at Yonsei University specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	490
2	Immunology	2	2	342
3	Health Sciences	1	1	23
4	Pathology	1	1	296
5	Pharmacology	1	1	56

Beung‐Chul Ahn

Publications

844

Citations

H-Index

Page 1

	Year	Citations
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer Chun‐Gon Kim, Kyoung‐Ho Kim, Kyoung‐Ho Pyo, Annals of Oncology Pd-1/pd-l1 BlockadeNon-small-cell Lung CancerAdvanced Lung DiseaseMedicineImmunology	2019	296
Characteristics and Outcome of ROS1-Positive Non–Small Cell Lung Cancer Patients in Routine Clinical Practice Sehhoon Park, Beung‐Chul Ahn, Sung Won Lim, Journal of Thoracic Oncology	2018	105
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice Beung‐Chul Ahn, Kyoung‐Ho Pyo, Chun-Feng Xin, Journal of Cancer Research and Clinical Oncology	2019	100
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience Seo-Young Lee, Hyo Sup Shim, Beung‐Chul Ahn, Cancer Immunology Immunotherapy OncologyMedicineSingle-center ExperienceFirst-line TreatmentPharmacotherapy	2021	56
Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer Chang Gon Kim, Min Hee Hong, Kyung Hwan Kim, European Journal of Cancer Lymphoid NeoplasiaDynamic ChangesCancer ImmunosurveillancePd-1 BlockadeMedicine	2020	46
A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC) S. Lee, Beung‐Chul Ahn, Sung Yoon Park, Annals of Oncology Esophageal CancerPhase Ii TrialSquamous Cell CarcinomaMedicinePreoperative Chemoradiotherapy	2019	37
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma Seok‐Young Kim, Ji Yeon Lee, Donghwi Kim, Scientific Reports	2019	34
Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer Beung‐Chul Ahn, Jea-Woo So, Chun-Bong Synn, European Journal of Cancer Death-1 TherapyPrognostic EvaluationOncologyMachine LearningClinical Decision Support System	2021	32
Real-World Analysis of the Efficacy of Rebiopsy and<i>EGFR</i>Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer Min Hee Hong, Hye Ryun Kim, Beung‐Chul Ahn, Yonsei Medical Journal	2019	25
FP03.02 Interim Analysis of Neoadjuvant Chemoradiotherapy and Durvalumab for Potentially Resectable Stage III Non-Small Cell Lung Cancer (NSCLC) Min Hee Hong, Beung‐Chul Ahn, H.R. Kim, Journal of Thoracic Oncology Surgical OncologyNeoadjuvant ChemoradiotherapyFp03.02 Interim AnalysisMedicineBronchial Neoplasm	2021	23

Page 1